(Q33409568)

English

Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

3

object named as

Huib N Caron

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Godelieve A. M. Tytgat

7

object named as

Godelieve A Tytgat

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

object named as

Gitta Bleeker

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Reineke A Schoot

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jan de Kraker

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cees A Hoefnagel

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Berthe L van Eck

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

7 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1711-1717

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

copyright license

Creative Commons Attribution-NonCommercial 2.0 Generic

7 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788185

28 July 2018

Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788185

28 July 2018

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788185

28 July 2018

Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788185

28 July 2018

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788185

28 July 2018

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788185

28 July 2018

First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788185

28 July 2018

Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2510-Z

21 January 2018

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2510-Z

21 January 2018

Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2510-Z

21 January 2018

Hypertension complicating 131I-meta-iodobenzylguanidine therapy for neuroblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2510-Z

21 January 2018

Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of 131I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/23921531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-013-2510-Z

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33409568&oldid=2195333577"